Abadan, Melanie U.
HRN: 09-66-74 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
CO-AMOXICLAV 625MG (TAB)
03/21/2026
03/27/2026
PO
625mg
TID
UTI
Checking Initial Appropriateness